A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance

Samir Mouhssine; Nawar Maher; Gianluca Gaidano

doi:10.21037/tcr-23-1396

A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance

Transl Cancer Res. 2023 Nov 30;12(11):2970-2975. doi: 10.21037/tcr-23-1396. Epub 2023 Nov 17.

Authors

Samir Mouhssine^{1

2}, Nawar Maher^{1

2}, Gianluca Gaidano^{1

2}

Affiliations

¹ Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
² Division of Hematology, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

No abstract available

Keywords: Large B cell lymphoma (LBCL); axicabtagene ciloleucel (axi-cel); chimeric antigen receptor (CAR)-T cells; simultaneous tumor and effector profiling; treatment resistance.

Publication types

Editorial
Comment